Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06543979

Anorectal Manometery in Pediatric Chronic Refractory Constipation

Anorectal manometry and high-resolution anorectal manometry (HRAM) are becoming the investigation of choice for understanding the pathophysiology of chronic constipation with or without fecal incontenance in children in many institutions. In high resolution anorectal manometery we are able to gain information whether the symptoms are related to sphincter dysfunction, impaired sensation, or pelvic floor dyssynergia

Recruiting

Interested in participating?

Request Info

Key information

Age range

4 year–16 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

About this study

Primary objective: To assess different patterns of anorectal manometry in children with chronic refractory constipation with or without fecal incontinence.

Secondary objective: To determine the effectiveness of different modalities of treatment of chronic refractory constipation based on the anorectal findings. To assess the safety ,tolerability and effectiveness of lubiprostone in pediatric age group with chronic refractory constipation. To assess the effect of elimination of cow milk products in patient with chronic refractory constipation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children and adolescents aged from 4 to 16 years.
  • Participants fulfilling Rome IV criteria for the diagnosis of functional constipation.

At least 2 of the following present at least once per week for at least 1 month:

  • 2 or fewer defecations in the toilet per week
  • At least 1 episode of fecal incontinence per week
  • History of retentive posturing or excessive volitional stool retention
  • History of painful or hard bowel movements
  • Presence of a large fecal mass in the rectum
  • History of large-diameter stools that may obstruct the toilet The symptoms cannot be fully explained by another medical condition (Hyams et al., 2016).
  • Participants who have chronic refractory constipation. Chronic refractory constipation (CRC) is defined as children who are unable to pass stools in spite of being on maximum laxative therapy and require daily rectal stimulation in the form of enemas or suppositories to pass stools 4-Is willing and able to keep a diary on his/her own and willing and able to complete a questionnaire.

5-The participant or, when applicable, the participant's legally acceptable representative signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.

Exclusion criteria

  • participants who have anorectal malformation
  • participants who have neurological disease affecting lower limbs
  • Has a history of hypersensitivity or allergies to lubiprostone

Treatment and study plan

lubiprostone , single arm

Drug

laxative

Other names: lubicont

biofeed back sessions

Procedure

Biofeedback for participants with dyssynergic defecation and participants with reduced rectal sensations

botox injection

Procedure

Botulinum toxin injection for participants suffering from elevated anal canal pressure

Primary outcomes

  1. To evaluate the manometric parameters in children with chronic refractory constipation

    Time frame: 1 year

    To measure the percent of the most common manometric parameters in children with chronic refractory constipation e.g dyssengeric defecation and reduced rectal sensetivity and anal sphincter dysfunction.

  2. evaluate the efficacy of oral administration of lubiprostone 8 and 24 μg once daily for 4 weeks in participants with chronic refractory constipation

    Time frame: 1 month

    Spontaneous Bowel Movement (SBM) Frequency at Week 1,2,3 and 4 A SBM was defined as any bowel movement (BM) that does not occur within 24 hours after rescue medication use (laxative, suppository, or enema). Participants will be given a diary to complete at home where they will record all details of each SBM including the consistency of the stool and the difficulty they have in passing it.

Secondary outcomes

  1. To determine the effect of biofeed back sessions in children with dyssengeric defecation and in children with rectal hyposensetivity

    Time frame: 3 months

    Participants with chronic refractory constipation and manometry parameters showed dyssengeric defecation or hyposensitivity will receive biofeedback sessions and the investigators measure the difference in bowel management scoring tool before and after the biofeedback sessions the higher the score the worest the condition

  2. To determine the effect of cow milk protein free diet on chronic refractory constipation in children

    Time frame: 1 month

    Participants will receive cow milk free diet for 4 weeks and investigators measure the difference in bowel management scoring tool before and after cow milk free diet the higher the score the worest the condition

  3. To determine the effect of botulinum toxin injection in children with elevated anal canal resting pressure

    Time frame: 3 month

    Participants with chronic refractory and manometric parameters showed high anal canal resting pressure will have botulinum toxin injection and investigators measure the difference in bowel management scoring tool before and after the injection the higher the score the worest the condition

Study contacts

Contact information is provided by the study sponsor or research team.

asmaa abdelnaby mohamed soliman, master

CONTACT

[email protected]

+2001070689789

yosra mohamed mohsen awad, MD

CONTACT

01001831590

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

The Diagnostic Value of Anorectal Manometry in Pediatric Chronic Refractory Constipation With or Without Fecal Incontinence

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 9, 2024
Registry last updated
Oct 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.